Demographic and Clinical Characteristics of Persons with HIV with Viral Load:Adherence Mismatch Who Are at Risk of Future Viremia
- 1 January 2023
- journal article
- research article
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 39 (1), 33-37
- https://doi.org/10.1089/aid.2021.0218
Abstract
The potency of modern antiretroviral therapy (ART) allows for greater forgiveness to missed doses while still achieving, and maintaining, viral suppression. However, imperfect ART adherence, even if sufficient to maintain viral suppression, has been associated with adverse clinical outcomes. ART adherence can be objectively quantified using tenofovir diphosphate (TFV-DP) in dried blood spots (DBS), a biomarker of cumulative adherence that is predictive of future viremia—even among persons with HIV (PWH) with an undetectable HIV viral load (VL). Within a prospective cohort of PWH on tenofovir disoproxil fumarate-including ART, mismatch between drug concentration and HIV VL (i.e., low concentrations of TFV-DP in DBS in the setting of viral suppression with subsequent viremia at the following visit) was observed more frequently in PWH who were Black (36% vs. 15%; p = .04), had body mass index >30 kg/m2 (40% vs. 13%; p = .01), and reported p = .005) and 30 days (56% vs. 31%; p = .001) adherence, compared with PWH without mismatch. Identifying PWH at risk for future viremia could help clinicians implement targeted timely interventions before episodes of breakthrough viremia.Keywords
This publication has 15 references indexed in Scilit:
- Association of Incomplete Adherence to Antiretroviral Therapy With Cardiovascular Events and Mortality in Virologically Suppressed Persons With HIV: The Swiss HIV Cohort StudyOpen Forum Infectious Diseases, 2021
- Direct quantitation of tenofovir diphosphate in human blood with mass spectrometry for adherence monitoringAnalytical and Bioanalytical Chemistry, 2020
- Antiretroviral Adherence Level Necessary for HIV Viral Suppression Using Real-World DataJAIDS Journal of Acquired Immune Deficiency Syndromes, 2019
- Incomplete ART adherence is associated with higher inflammation in individuals who achieved virologic suppression in the START studyJournal of the International AIDS Society, 2019
- Predictive Value of Tenofovir Diphosphate in Dried Blood Spots for Future Viremia in Persons Living With HIVThe Journal of Infectious Diseases, 2019
- Tenofovir Diphosphate in Dried Blood Spots Is Strongly Associated With Viral Suppression in Individuals With Human Immunodeficiency Virus InfectionsClinical Infectious Diseases, 2018
- Suboptimal Adherence to Combination Antiretroviral Therapy Is Associated With Higher Levels of Inflammation Despite HIV SuppressionClinical Infectious Diseases, 2016
- Adherence and HIV RNA Suppression in the Current Era of Highly Active Antiretroviral TherapyJAIDS Journal of Acquired Immune Deficiency Syndromes, 2015
- The Effect of Lopinavir/Ritonavir on the Renal Clearance of Tenofovir in HIV-infected PatientsClinical Pharmacology & Therapeutics, 2007
- Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV InfectionAnnals of Internal Medicine, 2000